These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1184 related articles for article (PubMed ID: 22098312)
21. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice. Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322 [TBL] [Abstract][Full Text] [Related]
22. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice]. Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372 [TBL] [Abstract][Full Text] [Related]
23. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models. Duramad O; Laysang A; Li J; Ishii Y; Namikawa R Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405 [TBL] [Abstract][Full Text] [Related]
24. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544 [TBL] [Abstract][Full Text] [Related]
25. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956 [TBL] [Abstract][Full Text] [Related]
26. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model. Jeon EJ; Yoon BY; Lim JY; Oh HJ; Park HS; Park MJ; Lim MA; Park MK; Kim KW; Cho ML; Cho SG Autoimmunity; 2012 Sep; 45(6):460-9. PubMed ID: 22559266 [TBL] [Abstract][Full Text] [Related]
27. Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease. Kim J; Kim W; Kim HJ; Park S; Kim HA; Jung D; Choi HJ; Park SJ; Mittler RS; Cho HR; Kwon B Biol Blood Marrow Transplant; 2012 Jan; 18(1):44-54. PubMed ID: 21958951 [TBL] [Abstract][Full Text] [Related]
28. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002 [TBL] [Abstract][Full Text] [Related]
29. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688 [TBL] [Abstract][Full Text] [Related]
30. Prevention of graft-versus-host diseases by in vivo supCD28mAb-expanded antigen-specific nTreg cells. Kitazawa Y; Li XK; Liu Z; Kimura H; Isaka Y; Hünig T; Takahara S Cell Transplant; 2010; 19(6):765-74. PubMed ID: 20573297 [TBL] [Abstract][Full Text] [Related]
31. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival. Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068 [TBL] [Abstract][Full Text] [Related]
32. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells. Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494 [TBL] [Abstract][Full Text] [Related]
33. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation. Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510 [TBL] [Abstract][Full Text] [Related]
34. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15. Lee CC; Lin SJ; Cheng PJ; Kuo ML Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176 [TBL] [Abstract][Full Text] [Related]
35. Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood. Fan H; Yang J; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Gao F; Liu M Immunology; 2012 Jun; 136(2):218-30. PubMed ID: 22348606 [TBL] [Abstract][Full Text] [Related]
36. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells. Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757 [TBL] [Abstract][Full Text] [Related]
38. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134 [TBL] [Abstract][Full Text] [Related]
39. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583 [TBL] [Abstract][Full Text] [Related]
40. Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Nguyen VH; Zeiser R; Negrin RS Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]